RE:Results Yeah, mediocre on CLI, absolutely now I understand why TS was highlighting the Phase II trial was about demonstrating safety of the treatment. It does look safe, but the effectiveness is underwhelming at best. With a bigger sample we'd know better, but argh this is going to take long, and take a lot more $. I hope the cardio path takes us somewhere faster. GLTA